[ET Net News Agency, 6 March 2026] DUALITYBIO-B (09606) rose 10.7% to HK$322.4.
It hits an intra-day high of HK$322.4, breaking above the 10-D SMA of HK$314.94, and an
intra-day low of HK$281.2. The total shares traded was 1.25 million, with a value of
HK$385.54m. The active buy/sell ratio is 66:34, with net buying turnover of HK$121.5m.
CHINA INNOVATION MARKET SER accounts for greatest net responsive buying turnover of
HK$36.91m, with volume weighted average price of HK$308.977. UBS accounts for greatest net
responsive selling turnover of HK$54.38m, with volume weighted average price of
HK$309.498. The stock has risen a combined 13.1% over the past 2 consecutive trading days.

Basic Information
=================

-----------------------------------
Nominal 322.400 % Chg +10.71%
High 322.400 Low 281.200
Shares Tr 1.25m Turnover 385.54m
10-D SMA 314.940 %H.V 42.567
20-D SMA 322.690 VWAP 309.218
50-D SMA 330.096 RSI14 50.142
-----------------------------------
Status: Breaking above the 10-D SMA, active buy/sell ratio is 66:34, with net buying
turnover of HK$121.5m, rising a combined 13.1% over the past 2 consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
DUALITYBIO-B (09606) 322.40 +10.71
HUTCHMED (00013) 22.06 +4.75
INNOVENT BIO (01801) 83.30 +6.18
XTALPI (02228) 10.07 +3.49
WUXI BIO (02269) 35.58 +0.40
WUXI APPTEC (02359) 111.60 +2.86
TRANSTHERA-B (02617) 87.60 +36.66
BEONE MEDICINES (06160) 182.40 +2.70
AKESO (09926) 107.00 +4.90
REMEGEN (09995) 85.45 +11.12
-----------------------------------------------
(ed)